Dulaglutide use to improve binge eating behaviors in a person with type 2 diabetes and obesity
This case report describes the use of dulaglutide in the management of mild BED in the setting of comorbid type 2 diabetes and obesity. Further research is necessary to evaluate the long-term effectiveness of GLP-1 RAs in the management of BED and to determine the optimal duration and dose.
Authors
- Kevin Cowart (ORCID: https://orcid.org/0000-0002-6880-1600)
- Raechel T. White (ORCID: https://orcid.org/0000-0002-5929-5590)
- Amre A Elmaoued
- Britnee Innocent
Institutions
- University of New Mexico (US)
- University of South Florida (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2025-04-12
- DOI
- https://doi.org/10.1093/ajhp/zxaf088
- Citations
- 2
- Primary Topic
- Eating Disorders and Behaviors
- Type
- article
- Field-Weighted Citation Impact
- 4.61